The Drug Synthesis and Chemistry Branch (DS&CB) of the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment (DCT) of the National Cancer Institute (NCI) is seeking contractors with chemical synthesis expertise to synthesis a variety of compounds for evaluation as potential anticancer agents. The objectives of this project are to: synthesize congeners of synthetic compounds with confirmed activity; design and synthesize """"""""pro-drugs"""""""" and other compounds that possess elements of both congener and pro-drug; and synthesize compounds related to products of natural origin and other related heterocycles.
Moyer, J D; Reizes, O; Ahir, S et al. (1988) Substrate properties of analogs of myo-inositol. Mol Pharmacol 33:683-9 |
Baker, D C; Hand, E S; Plowman, J et al. (1987) Synthesis, chemical stability and pre-clinical anti-tumor activity of pyrazine diazohydroxide, sodium salt (NSC-361456). Anticancer Drug Des 2:297-309 |